TLR9 expression in glioma tissues correlated to glioma progression and the prognosis of GBM patients

TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas

(2014) O. M. Grauer et al.   JOURNAL OF IMMUNOLOGY

Intracerebral administration of CpG oligonucleotide for patients with recurrent glioblastoma: a phase II study

(2011) A. Carpentier et al.   NEURO-ONCOLOGY

Brain tumor epidemiology: Consensus from the Brain Tumor Epidemiology Consortium

(2010) Melissa L. Bondy et al.   CANCER

Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists

(2009) Jörg Vollmer et al.   ADVANCED DRUG DELIVERY REVIEWS

Increase in tumor size following intratumoral injection of immunostimulatory CpG-containing oligonucleotides in a rat glioma model

(2009) Christian Ginzkey et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

A Proviral Role for CpG in Cytomegalovirus Infection

(2009) A.-C. Iversen et al.   JOURNAL OF IMMUNOLOGY

Plasma IGFBP-2 levels predict clinical outcomes of patients with high-grade gliomas

(2009) Yi Lin et al.   NEURO-ONCOLOGY

Operative techniques for gliomas and the value of extent of resection

(2009) Nader Sanai et al.   Neurotherapeutics

Detection of human cytomegalovirus in different histological types of gliomas

(2008) Michael E. Scheurer et al.   ACTA NEUROPATHOLOGICA

Toll-Like Receptor-9 Expression Is Inversely Correlated with Estrogen Receptor Status in Breast Cancer

(2008) Arja Jukkola-Vuorinen et al.   Journal of Innate Immunity

Expression of TLR9 within human glioblastoma

(2008) Yuxia Meng et al.   JOURNAL OF NEURO-ONCOLOGY

Toll-Like Receptor 9 Mediates CpG Oligonucleotide-Induced Cellular Invasion

(2008) J. M. Ilvesaro et al.   MOLECULAR CANCER RESEARCH

The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

(2008) Prakash Chinnaiyan et al.   Radiation Oncology

Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma

(2007) Duane A. Mitchell et al.   NEURO-ONCOLOGY